Scientists are harnessing the body’s immune system to treat cancer with adoptive cell therapies. CAR T-cell or chimeric antigen receptor T-cell therapy, specifically, modifies T-cells to destroy cancer cells. Carter BloodCare has been entrusted to assist with initial collection, cryopreservation, preparation for patient infusion and administration of the cell product.
Our Commitment to you.
Community – Serving our partners, locally and globally.
Customer Service – Caring is in our DNA.
Turn-Around Time – Delivering reliable 24/7 service with access to expert consultation.
Quality – Inspiring confidence and pursuing innovation at every opportunity.
Value – Exceeding the expectations of our partners through fiscal responsibility.
A look behind the scenes of stem cell processing and cryopreservation.